Quick Answer
Cue Biopharma, Inc. reported Common Stock Shares Outstanding of 96.62 million shares for the year ending 2025.
- Cue Biopharma, Inc. showed an increase of +56.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Cue Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Cue Biopharma, Inc.'s Common Stock Shares Outstanding has grown by 396.5%.
- Historical annual values: Fiscal year 2025: 96.62 million shares | Fiscal year 2024: 61.82 million shares | Fiscal year 2023: 47.22 million shares | Fiscal year 2022: 47.22 million shares | Fiscal year 2021: 32.20 million shares | Fiscal year 2020: 30.35 million shares | Fiscal year 2019: 26.56 million shares | Fiscal year 2018: 20.70 million shares | Fiscal year 2017: 19.46 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: